Moniek A de Witte1,2, Jürgen Kuball2,3, Jeffrey S Miller1. 1. Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN. 2. Department of Hematology, Cancer Center, University Medical Centre Utrecht, Utrecht, The Netherlands. 3. Laboratory of Translational Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Abstract
PURPOSE OF REVIEW: The outcome of allogeneic stem cell transplantation (allo-HCT) is still compromised by relapse and complications. NK cells and γδT cells, effectors which both function through MHC-unrestricted mechanisms, can target transformed and infected cells without inducing Graft-versus-Host Disease (GVHD). Allo-HCT platforms based on CD34+ selection or αβ-TCR depletion result in low grades of GVHD, early immune reconstitution (IR) of NK and γδT cells and minimal usage of GVHD prophylaxis. In this review we will discuss strategies to retain and expand the quantity, diversity and functionality of these reconstituting innate cell types. RECENT FINDINGS: Bisphosphonates, IL-15 cytokine administration, specific antibodies, checkpoint inhibitors and (CMV based) vaccination are currently being evaluated to enhance IR. All these approaches have shown to potentially enhance both NK and γδT cell immuno-repertoires. SUMMARY: Rapidly accumulating data linking innate biology to proposed clinical immune interventions, will give unique opportunities to unravel shared pathways which determine the Graft-versus-Tumor effects of NK and γδT cells.
PURPOSE OF REVIEW: The outcome of allogeneic stem cell transplantation (allo-HCT) is still compromised by relapse and complications. NK cells and γδT cells, effectors which both function through MHC-unrestricted mechanisms, can target transformed and infected cells without inducing Graft-versus-Host Disease (GVHD). Allo-HCT platforms based on CD34+ selection or αβ-TCR depletion result in low grades of GVHD, early immune reconstitution (IR) of NK and γδT cells and minimal usage of GVHD prophylaxis. In this review we will discuss strategies to retain and expand the quantity, diversity and functionality of these reconstituting innate cell types. RECENT FINDINGS: Bisphosphonates, IL-15 cytokine administration, specific antibodies, checkpoint inhibitors and (CMV based) vaccination are currently being evaluated to enhance IR. All these approaches have shown to potentially enhance both NK and γδT cell immuno-repertoires. SUMMARY: Rapidly accumulating data linking innate biology to proposed clinical immune interventions, will give unique opportunities to unravel shared pathways which determine the Graft-versus-Tumor effects of NK and γδT cells.
Authors: Kilian Wistuba-Hamprecht; Alexander Martens; Karin Haehnel; Marnix Geukes Foppen; Jianda Yuan; Michael A Postow; Phillip Wong; Emanuela Romano; Amir Khammari; Brigitte Dreno; Mariaelena Capone; Paolo A Ascierto; Ilja Demuth; Elisabeth Steinhagen-Thiessen; Anis Larbi; Bastian Schilling; Dirk Schadendorf; Jedd D Wolchok; Christian U Blank; Graham Pawelec; Claus Garbe; Benjamin Weide Journal: Eur J Cancer Date: 2016-07-09 Impact factor: 9.162
Authors: Christelle Harly; Yves Guillaume; Steven Nedellec; Cassie-Marie Peigné; Hannu Mönkkönen; Jukka Mönkkönen; Jianqiang Li; Jürgen Kuball; Erin J Adams; Sonia Netzer; Julie Déchanet-Merville; Alexandra Léger; Thomas Herrmann; Richard Breathnach; Daniel Olive; Marc Bonneville; Emmanuel Scotet Journal: Blood Date: 2012-07-05 Impact factor: 22.113
Authors: Ahmet H Elmaagacli; Nina K Steckel; Michael Koldehoff; Yael Hegerfeldt; Rudolf Trenschel; Markus Ditschkowski; Sandra Christoph; Tanja Gromke; Lambros Kordelas; Hellmut D Ottinger; Rudolf S Ross; Peter A Horn; Susanne Schnittger; Dietrich W Beelen Journal: Blood Date: 2011-05-03 Impact factor: 22.113
Authors: Leo Luznik; Javier Bolaños-Meade; Marianna Zahurak; Allen R Chen; B Douglas Smith; Robert Brodsky; Carol Ann Huff; Ivan Borrello; William Matsui; Jonathan D Powell; Yvette Kasamon; Steven N Goodman; Allan Hess; Hyam I Levitsky; Richard F Ambinder; Richard J Jones; Ephraim J Fuchs Journal: Blood Date: 2010-02-02 Impact factor: 22.113
Authors: Michael Boeckh; W Garrett Nichols; Genovefa Papanicolaou; Robert Rubin; John R Wingard; John Zaia Journal: Biol Blood Marrow Transplant Date: 2003-09 Impact factor: 5.742
Authors: S A Rosenberg; J C Yang; S L Topalian; D J Schwartzentruber; J S Weber; D R Parkinson; C A Seipp; J H Einhorn; D E White Journal: JAMA Date: 1994 Mar 23-30 Impact factor: 56.272
Authors: Moniek A de Witte; Anke Janssen; Klaartje Nijssen; Froso Karaiskaki; Luuk Swanenberg; Anna van Rhenen; Rick Admiraal; Lotte van der Wagen; Monique C Minnema; Eefke Petersen; Reinier A P Raymakers; Kasper Westinga; Trudy Straetemans; Constantijn J M Halkes; Jaap-Jan Boelens; Jürgen Kuball Journal: Blood Adv Date: 2021-01-12
Authors: Moniek A de Witte; Dhifaf Sarhan; Zachary Davis; Martin Felices; Daniel A Vallera; Peter Hinderlie; Julie Curtsinger; Sarah Cooley; John Wagner; Jurgen Kuball; Jeffrey S Miller Journal: Biol Blood Marrow Transplant Date: 2018-03-02 Impact factor: 5.742
Authors: Lia Minculescu; Henrik Sengelov; Hanne Vibeke Marquart; Lars Peter Ryder; Anne Fischer-Nielsen; Eva Haastrup Journal: Front Immunol Date: 2021-03-10 Impact factor: 7.561
Authors: Hermann Einsele; Javier Briones; Fabio Ciceri; Irene García Cadenas; Fred Falkenburg; Natacha Bolaños; H M Mirjam Heemskerk; Roch Houot; Michael Hudecek; Franco Locatelli; Kate Morgan; Emma C Morris; Michael O'Dwyer; Jordi Gil Sierra; Marcel van den Brink; Arjan A van de Loosdrecht Journal: Hemasphere Date: 2021-09-10
Authors: Moniek de Witte; Laura G M Daenen; Lotte van der Wagen; Anna van Rhenen; Reiner Raymakers; Kasper Westinga; Jürgen Kuball Journal: Hemasphere Date: 2021-06-01
Authors: Lia Minculescu; Hanne Vibeke Marquart; Lars Peter Ryder; Niels Smedegaard Andersen; Ida Schjoedt; Lone Smidstrup Friis; Brian Thomas Kornblit; Søren Lykke Petersen; Eva Haastrup; Anne Fischer-Nielsen; Joanne Reekie; Henrik Sengelov Journal: Front Immunol Date: 2019-08-22 Impact factor: 7.561
Authors: Volker Wiebking; Ciaran M Lee; Nathalie Mostrel; Premanjali Lahiri; Rasmus Bak; Gang Bao; Maria Grazia Roncarolo; Alice Bertaina; Matthew H Porteus Journal: Haematologica Date: 2021-03-01 Impact factor: 9.941